Treatment and endpoints. – AIEOP-BFM ALL – AIEOP-BFM ALL • Perspectives. ALL, acute lymphoblastic leukemia; MRD, minimal residual disease. Principal investigator of clinical trial. Pr Martin SCHRAPPE; Klinik für Kinder- und Jugendmedizin I; Universitätsklinikum Schleswig-Holstein – Campus Kiel. Blood ; doi: .. Accordingly, in the AIEOP-BFM ALL study, these 2 groups of patients.
|Published (Last):||25 August 2010|
|PDF File Size:||9.5 Mb|
|ePub File Size:||17.38 Mb|
|Price:||Free* [*Free Regsitration Required]|
Cancer AND drug name. Pneumonia AND sponsor name. How to search [pdf]. For these items you should use the filters and not add them to your aiieop-bfm terms in the text field.
Clinical Trials Register
Trials with results Trials without results Clear advanced search filters. Download Options Subscribe to this Search. Displaying page 1 of 1.
International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia Medical condition: Children, Adolescents, Under 18 Gender: Male, Female Trial protocol: No results available EudraCT Number: Anna Kinderkrebsforschung Full Title: This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days. Date study was submitted in EudraCT. Query did not match any studies. EU Clinical Trials Register.
Both Female Only Male Only. IMP with orphan designation in the indication.
Trials with results Trials without results. Clear advanced search filters. Information not available in Aieop-bmf. International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia.
Infants and toddlers, Children, Adolescents, Under 18, Adults. Trials shown on current page Selected Trials only. Summary Details Full Trial Details.